Comparing Carbon Dioxide Monitoring Methods During Jet Ventilation in Liver Tumor Treatment

What this Trial Is About

Researchers are comparing two methods of monitoring carbon dioxide levels during jet ventilation in patients undergoing percutaneous liver tumour radiofrequency ablation. Jet ventilation is used to reduce diaphragm movement during the procedure, improving conditions for the radiologist and reducing risk to surrounding tissue. Since standard end-tidal CO2 monitoring is not possible with jet ventilation, this study evaluates transcutaneous through the skin monitoring against arterial blood sampling to determine any differences between the two methods. Participants will receive the usual preoperative care and jet ventilation as per standard protocols. The study involves collecting data on carbon dioxide levels using both transcutaneous and arterial blood gas monitoring methods during the procedure. The data will be analyzed prospectively to assess discrepancies between the two monitoring techniques. Patients will contribute data during their routine care without any additional interventions. Researchers will measure the difference in carbon dioxide levels between the two methods during perioperative management. All patients will be monitored as usual, and the study will track data to analyze the accuracy and reliability of each monitoring method. Participation involves no change to standard treatment and will last only for the duration of the procedure and immediate perioperative period.

Comparison of Transcutaneous and Arterial Carbon Dioxide Sampling During Jet Ventilation, a Prospective. Study on Patients Undergoing Percutaneous Liver Tumour Radiofrequency Ablation